The British Society for Rheumatology Biologics Registers in Ankylosing Spondylitis (BSRBR-AS) study: Protocol for a prospective cohort study of the long-term safety and quality of life outcomes of biologic treatment

BACKGROUND: Axial spondyloarthropathy typically has its onset in early adulthood and can impact significantly on quality of life. In the UK, biologic anti-tumour necrosis factor therapy is recommended for patients who are unresponsive to non-steroidal anti-inflammatory drugs. There remain several un...

Descripción completa

Detalles Bibliográficos
Autores principales: Macfarlane, Gary J., Barnish, Maxwell S., Jones, Elizabeth A., Kay, Lesley, Keat, Andrew, Meldrum, Karen T., Pathan, Ejaz, Sturrock, Roger D., Zabke, Claudia, McNamee, Paul, Jones, Gareth T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4642769/
https://www.ncbi.nlm.nih.gov/pubmed/26559487
http://dx.doi.org/10.1186/s12891-015-0805-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4642769/
https://www.ncbi.nlm.nih.gov/pubmed/26559487
http://dx.doi.org/10.1186/s12891-015-0805-x

Ejemplares similares